FAKTOR OPTIONSSCHEIN - MEDTRONIC Stock

Certificat

DE000UH2W2P3

Delayed Deutsche Boerse AG 02:30:26 2024-06-26 EDT
2.3 EUR -5.74% Intraday chart for FAKTOR OPTIONSSCHEIN - MEDTRONIC
Current month+3.83%
1 month+11.42%
Date Price Change
24-06-26 2.3 -5.74%
24-06-25 2.44 +7.96%
24-06-24 2.26 -1.31%
24-06-21 2.29 -8.03%
24-06-20 2.49 +4.18%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 02:30 am

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying MEDTRONIC PLC
Issuer UBS
WKN UH2W2P
ISINDE000UH2W2P3
Date issued 2021-10-14
Strike 94.55 $
Maturity Unlimited
Parity 5.39 : 1
Emission price 5.03
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 17.2
Lowest since issue 1.63
Spread 0.1
Spread %4.00%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
80.41 USD
Average target price
94.02 USD
Spread / Average Target
+16.93%
Consensus